• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Synopsys

Synopsys

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. SNP Trace Panel Proves to Be a High-Throughput, Cost-Effective SNP-Based Platform for Profiling Human Tissue and Cell Lines

    SNP Trace Panel Proves to Be a High-Throughput, Cost-Effective SNP-Based Platform for Profiling Human Tissue and Cell Lines

  2. Ceres Becomes Oracle PartnerNetwork Gold Level Partner

    Ceres Becomes Oracle PartnerNetwork Gold Level Partner

  3. Volatility: The New Normal

    At a conference hosted by an electronic design automation (EDA) firm, we were able to survey engineers and executives in the field about what they believe is going on in the EDA world. While the information we gained was more qualitative than quantitative, we believe it provides interesting and ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.